A Post-marketing Surveillance Looking at Safety and Adherence to Treatment of Enbrel in Adults With Active Rheumatoid Arthritis in Luxemburg.

Trial Profile

A Post-marketing Surveillance Looking at Safety and Adherence to Treatment of Enbrel in Adults With Active Rheumatoid Arthritis in Luxemburg.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jan 2012

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Pfizer; Wyeth
  • Most Recent Events

    • 21 Jan 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 21 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Apr 2011 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top